The TCR Repertoire: A Window Into Pediatric Brain Tumor Immunity Get access

IL-13Rα2/TGF-β bispecific CAR-T cells counter TGF-β-mediated immune suppression and potentiate anti-tumor responses in glioblastoma Get access

• Abstract
• Supplementary data

Commentary on “Dysfunctional dendritic cells limit antigen-specific T cell response in glioma”

• Extract

Diffusion MRI is an early biomarker of overall survival benefit in IDH wild-type recurrent glioblastoma treated with immune checkpoint inhibitors

• Abstract
• Supplementary data

Unique challenges for glioblastoma immunotherapy—discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Meeting Report from the 2019 SNO Immuno-Oncology Think Tank

• Abstract

Emerging immunotherapies for malignant glioma: from immunogenomics to cell therapy

• Abstract

Metabolic characterization of human IDH mutant and wild type gliomas using simultaneous pH- and oxygen-sensitive molecular MRI

• Abstract
• Supplementary data

Immunosuppressive tumor-infiltrating myeloid cells mediate adaptive immune resistance via a PD-1/PD-L1 mechanism in glioblastoma

• Abstract
• Supplementary data

Efficacy of systemic adoptive transfer immunotherapy targeting NY-ESO-1 for glioblastoma

• Abstract

pH-weighted molecular imaging of gliomas using amine chemical exchange saturation transfer MRI

• Abstract
• Supplementary data

Cancer Immunotherapy at the Crossroads: How Tumors Evade Immunity and What Can Be Done Get access